ENDRA Life Sciences Files Preliminary Prospectus for Share, Warrant Offering

MT Newswires Live

Jul 09

ENDRA Life Sciences (NDRA) filed a preliminary prospectus Wednesday for its planned offering of 15.7 million common shares and pre-funded warrants to purchase up to the same number of shares.

The company said it granted the underwriter a 45-day option to purchase up to about 2.4 million additional common shares. ENDRA will also issue underwriter warrants to purchase up to 628,000 common shares.

ENDRA said the pricing is yet to be determined with the underwriter.

Shares of ENDRA were down more than 15% in recent Wednesday trading.

Price: 7.05, Change: -1.25, Percent Change: -15.06

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2550561366"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2550561366\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2550561366?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-09 22:37","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2550561366","market":"nz","top_or_hot":-1,"title":"ENDRA Life Sciences Files Preliminary Prospectus for Share, Warrant Offering","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/NDRA\">ENDRA Life</a> Sciences (NDRA) filed a preliminary prospectus Wednesday for its planned offering of 15.7 million common shares and pre-funded warrants to purchase up to the same number of shares.</p><p>The company said it granted the underwriter a 45-day option to purchase up to about 2.4 million additional common shares. ENDRA will also issue underwriter warrants to purchase up to 628,000 common shares.</p><p>ENDRA said the pricing is yet to be determined with the underwriter.</p><p>Shares of ENDRA were down more than 15% in recent Wednesday trading.</p><p>Price: 7.05, Change: -1.25, Percent Change: -15.06</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ENDRA Life Sciences Files Preliminary Prospectus for Share, Warrant Offering</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nENDRA Life Sciences Files Preliminary Prospectus for Share, Warrant Offering\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-07-09 22:37</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/NDRA\">ENDRA Life</a> Sciences (NDRA) filed a preliminary prospectus Wednesday for its planned offering of 15.7 million common shares and pre-funded warrants to purchase up to the same number of shares.</p><p>The company said it granted the underwriter a 45-day option to purchase up to about 2.4 million additional common shares. ENDRA will also issue underwriter warrants to purchase up to 628,000 common shares.</p><p>ENDRA said the pricing is yet to be determined with the underwriter.</p><p>Shares of ENDRA were down more than 15% in recent Wednesday trading.</p><p>Price: 7.05, Change: -1.25, Percent Change: -15.06</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"NDRA","symbol_name":"ENDRA Life Sciences Inc","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2550561366","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2550561366","pubTimestamp":1752071848,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"ENDRA Life Sciences  filed a preliminary prospectus Wednesday for its planned offering of 15.7 million common shares and pre-funded warrants to purchase up to the same number of shares.The company said it granted the underwriter a 45-day option to purchase up to about 2.4 million additional common shares. ENDRA will also issue underwriter warrants to purchase up to 628,000 common shares.ENDRA said the pricing is yet to be determined with the underwriter.Shares of ENDRA were down more than 15% in recent Wednesday trading.Price: 7.05, Change: -1.25, Percent Change: -15.06","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"NDRA":"ENDRA Life Sciences Inc","BK4082":"医疗保健设备"},"translate_title":"ENDRA Life Sciences提交股票和认股权证发行初步招股说明书","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NDRA":0.9},"content_text":"ENDRA Life Sciences (NDRA) filed a preliminary prospectus Wednesday for its planned offering of 15.7 million common shares and pre-funded warrants to purchase up to the same number of shares.The company said it granted the underwriter a 45-day option to purchase up to about 2.4 million additional common shares. ENDRA will also issue underwriter warrants to purchase up to 628,000 common shares.ENDRA said the pricing is yet to be determined with the underwriter.Shares of ENDRA were down more than 15% in recent Wednesday trading.Price: 7.05, Change: -1.25, Percent Change: -15.06","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}